Related Experiment Video
Updated: Jun 28, 2026
10:30
Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice
Published on: October 20, 2016
Hemicraniectomy for middle cerebral artery infarction
Hagen B Huttner1, Eric Jüttler, Stefan Schwab
1Department of Neurology, University of Erlangen, Erlangen, Germany.
Current Neurology and Neuroscience Reports
|October 30, 2008
Summary
Malignant middle cerebral artery infarction, a severe ischemic stroke, now has a proven treatment. Early hemicraniectomy significantly reduces mortality within 3 months, offering new hope for patients.
Area of Science:
- Neurology
- Neurosurgery
- Stroke Medicine
Background:
- Malignant middle cerebral artery infarction is a devastating form of ischemic stroke.
- Historically, effective treatments were lacking for this severe condition.
- Acute basilar artery occlusion is another highly lethal stroke type.
Purpose of the Study:
- To review current treatment options for malignant ischemic brain infarction.
- To focus on the role and efficacy of early hemicraniectomy.
- To discuss unsolved problems and future research directions.
Main Methods:
- Review of randomized controlled trials (RCTs) published up to 2007.
- Analysis of evidence supporting early hemicraniectomy.
- Discussion of clinical perspectives and open questions.
Main Results:
- Randomized controlled trials in 2007 demonstrated a mortality benefit from early hemicraniectomy.
- Early hemicraniectomy significantly reduces 3-month mortality in malignant ischemic stroke.
- Hemicraniectomy is now a proven treatment option.
Conclusions:
- Early hemicraniectomy is a crucial intervention for malignant middle cerebral artery infarction.
- Further research is needed to address remaining challenges and optimize patient outcomes.
- The review provides perspective on future clinical studies in stroke management.
